- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Journey Medical Corp (DERM)
Journey Medical Corp stock price live, this page displays NASDAQ DERM stock exchange data. View the DERM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Journey Medical Corp real time stock price chart below.
What Is the Journey Medical Corp Stock Price Today?
The Journey Medical Corp stock price today is 7.210.
What Is the Stock Symbol for Journey Medical Corp?
The stock symbol for Journey Medical Corp is ""DERM.""
What Stock Exchange Does Journey Medical Corp Trade On?
Journey Medical Corp is listed and trades on the NASDAQ stock exchange.
Is Journey Medical Corp a Good Stock to Buy?
Determining whether Journey Medical Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DERM quote. (ISIN: US48115J1097)
What Is the Journey Medical Corp Stock Price Today?
The Journey Medical Corp stock price today is 7.210.
What Is the Stock Symbol for Journey Medical Corp?
The stock symbol for Journey Medical Corp is ""DERM.""
What Stock Exchange Does Journey Medical Corp Trade On?
Journey Medical Corp is listed and trades on the NASDAQ stock exchange.
Is Journey Medical Corp a Good Stock to Buy?
Determining whether Journey Medical Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DERM quote. (ISIN: US48115J1097)
NASDAQ
Currency in USD
Fair Value
An estimate of a Journey Medical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.070
7.510
52 wk Range
3.535
8.900
DERM Scorecard
Full Analysis
Operates with a moderate level of debt
DERM is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Journey Medical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.0707.510
52 wk Range
3.5358.900
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DERM Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Journey Medical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
11.800
Upside
+63.66%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Not profitable over the last twelve months
- Journey Medical receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Journey Medical receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Journey Medical Corp Company Profile
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company’s marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also offers Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Emrosi for the treatment of inflammatory lesions of rosacea, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
Journey Medical Corp Earnings Call Summary for Q2/2025
- Q2 2025 EPS loss of $0.16, missing $0.11 forecast; revenue slightly exceeded at $15.01M vs $14.93M expected
- Stock rose 8.51% after-hours to $8.00, despite earnings miss; year-to-date gain of 101%
- New rosacea treatment Amrozi shows strong uptake with over 12,800 prescriptions
- Company aims to be EBITDA positive by end of 2025; no specific full-year guidance provided
- Analyst price targets suggest potential upside, ranging from $9 to $12 per share
Last Updated: 12/08/2025, 22:26
Read Full TranscriptCompare DERM to Peers and Sector
Metrics to compare | DERM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDERMPeersSector | |
|---|---|---|---|---|
P/E Ratio | −21.7x | −3.2x | −0.6x | |
PEG Ratio | 0.02 | 0.03 | 0.00 | |
Price/Book | 9.9x | 0.9x | 2.6x | |
Price / LTM Sales | 3.4x | 1.8x | 3.3x | |
Upside (Analyst Target) | 65.1% | 155.6% | 39.1% | |
Fair Value Upside | Unlock | 12.0% | 5.4% | Unlock |
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 11.800
(+63.66% Upside)
Earnings
Latest Release
Aug 12, 2025
EPS / Forecast
-0.16 / -0.11
Revenue / Forecast
15.01M / 14.93M
People Also Watch
FAQ
What Stock Exchange Does Journey Medical Trade On?
Journey Medical is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Journey Medical?
The stock symbol for Journey Medical is "DERM."
What Is the Journey Medical Market Cap?
As of today, Journey Medical market cap is 169.43M.
What Is Journey Medical's Earnings Per Share (TTM)?
The Journey Medical EPS (TTM) is -0.40.
When Is the Next Journey Medical Earnings Date?
Journey Medical will release its next earnings report on 04 Nov 2025.
From a Technical Analysis Perspective, Is DERM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Journey Medical Stock Split?
Journey Medical has split 0 times.
How Many Employees Does Journey Medical Have?
Journey Medical has 41 employees.
What is the current trading status of Journey Medical (DERM)?
As of 29 Aug 2025, Journey Medical (DERM) is trading at a price of 7.210, with a previous close of 7.27. The stock has fluctuated within a day range of 7.070 to 7.510, while its 52-week range spans from 3.535 to 8.900.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.